What is PT Bank Mandiri (Persero) Tbk / ADR (PPERY)'s fair-value range?

EvidInvest does not publish a fair-value range for PT Bank Mandiri (Persero) Tbk / ADR (PPERY). Financials are filed in IDR; our prices are in USD, so these methods need a conversion we do not yet publish. The filed statements, the filing citations and the growth history are all available at https://evidinvest.com/valuation/PPERY. Not investment advice.

How is PT Bank Mandiri (Persero) Tbk / ADR (PPERY)'s fair value calculated?

PT Bank Mandiri (Persero) Tbk / ADR (PPERY)'s fair value is computed with several independent methods — a discounted cash flow (DCF) model, the Graham number, earnings power value (EPV), and valuation multiples (PE, EV/EBITDA, P/S, P/B) benchmarked against its industry — using data from SEC filings.

What is PT Bank Mandiri (Persero) Tbk / ADR (PPERY)'s PE ratio versus its industry?

EvidInvest shows PT Bank Mandiri (Persero) Tbk / ADR (PPERY)'s current and historical PE ratio alongside its sector and industry averages, so you can see whether the stock trades at a premium or discount to peers. Full breakdown at https://evidinvest.com/valuation/PPERY.

Fair value · PT Bank Mandiri (Persero) Tbk / ADR (PPERY) · updated 2026-09-13 · from 20-F FY2025

PT Bank Mandiri (Persero) Tbk / ADR trades at $9.40. We are not reading assumptions out of that price: financials are filed in IDR; our prices are in USD, so these methods need a conversion we do not yet publish.

Everything below is unaffected: the filed statements, the filing they came from, and PPERY’s growth history are all as reported.

Check another stock

The filing behind these numbers

PT Bank Mandiri (Persero) Tbk / ADR

Revenue: IDR 205.54T
Diluted EPS: IDR 24338.80
Free cash flow: IDR 96.01T; operating cash flow − capital expenditure
Diluted shares: 2.33B; weighted average

20-F FY2025 · fiscal year ended 2025-12-31 · filed 2025-12-31

Trailing-twelve-month EPS also uses the quarterly 6-Ks through Q2 FY2026 (filed 2026-06-30).

Open the 20-F list on sec.govCIK 1461748

Valuation tool: build your own PPERY range

Fair Value Summary

Daily Price — PPERY

$8.74 -1.2% (1Y)

Your range0 of 8 methods

At least two methods need a usable value to draw a range with these inputs.

Range with preset inputs

No preset range for this company yet.

The two ranges are identical because every input sits on a preset.

We don’t tell you what PPERY is worth. Every tab OPENS on what today’s price implies for that method’s key assumption; you decide whether that assumption is reasonable — the growth matrix has PPERY’s filed history and the AI chat will reason it through with you — and the range you build is yours. Our presets are filed history and reference settings, never a recommendation.

Discounted cash flow

N/A

Financials are filed in IDR; our prices are in USD, so these methods need a conversion we do not yet publish.

Preset inputs — revenue-driven DCF from the latest filing

Implied by today’s price

Financials are filed in IDR; our prices are in USD, so these methods need a conversion we do not yet publish.

Not solvable from the price — Financials are filed in IDR; our prices are in USD, so these methods need a conversion we do not yet publish. Showing preset inputs.

This method has no key input to read out of the price. The others below do, and you set them yourself: the growth matrix shows what PPERY has actually filed, and the AI chat will reason it through with you.

Your inputs

Free cash flow grows at your stage-1 rate, then your stage-2 rate, then a terminal rate; everything is discounted at your WACC.

Stage-1 growth5.0%

Yearly free-cash-flow growth for the first stage. Starts below zero so a shrinking-cash-flow case — and the rate today’s price implies — can be set.

-20.0%60.0%

Stage-1 years5 yrs

How long stage-1 growth lasts.

1 yrs10 yrs

Stage-2 growth2.5%

Slower growth after stage 1, before the terminal phase.

-20.0%30.0%

Stage-2 years5 yrs

0 yrs10 yrs

Terminal growth2.5%

Growth forever after the two stages. Above ~3% is rarely justified.

0.0%5.0%

Discount rate (WACC)14.16%

The return you require. Default is the WACC EvidInvest computed for this company. Higher discount rate, lower value.

3.00%15.00%

Net debt ($M)Debt minus cash, from the balance sheet. Subtracted from enterprise value.

Starting FCF ($M)Latest free cash flow from the filing (operating cash flow minus capex).

Shares (M)Diluted shares, from the filing.

Year by year (two-stage model, $M)

PV explicit $607,534,221M · PV terminal $324,176,839M · EV $931,711,060M · equity $1,034,023,977M

Year	Stage	FCF	Present value
1	Stage 1	$100,813,745M	$88,309,167M
2	Stage 1	$105,854,432M	$81,223,392M
3	Stage 1	$111,147,153M	$74,706,169M
4	Stage 1	$116,704,511M	$68,711,875M
5	Stage 1	$122,539,737M	$63,198,554M
6	Stage 2	$125,603,230M	$56,743,621M
7	Stage 2	$128,743,311M	$50,947,978M
8	Stage 2	$131,961,893M	$45,744,286M
9	Stage 2	$135,260,941M	$41,072,086M
10	Stage 2	$138,642,464M	$36,877,092M

Inputs from the filing

Financials are filed in IDR; our prices are in USD, so these methods need a conversion we do not yet publish.

Free cash flow: IDR 37.71T; sum of the last four quarters
EBIT: IDR 76.97T; latest annual
Shares: 2.33B
Total debt: IDR 282.59T
Cash: IDR 384.91T
Net debt: IDR -102.31T; debt − cash

20-F FY2025 · period ended 2025-12-31 · filed 2025-12-31 · sec.gov

Prefer a blank slate with reverse DCF? Open the standalone DCF / reverse DCF for PPERY

Loading history...

PT Bank Mandiri (Persero) Tbk / ADR trades at $9.40. We are not reading assumptions out of that price: financials are filed in IDR; our prices are in USD, so these methods need a conversion we do not yet publish.

The filing behind these numbers

Valuation tool: build your own PPERY range

Daily Price — PPERY

Your range0 of 8 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on PPERY

Compare with peers

Explore

Valuation tool: build your own PPERY range

Daily Price — PPERY

Your range0 of 8 methods

Range with preset inputs

Your inputs

Year by year (two-stage model, $M)

More on PPERY

Compare with peers

Explore